insights_auto
Why is AGIO down 3,58%?
Dive Deeperchevron_right
AGIO:NASDAQ
Agios Pharmaceuticals Inc
30,46 USD
arrow_downward
-3,58%(-1,13) 1D
16-ноя., 13:56:31 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
31,29 USD
High
31,70 USD
Low
30,44 USD
Mkt. cap
1,82 млд
Avg. vol.
1,24 млн
Volume
153,01 миң
52-wk high
45,99 USD
52-wk low
22,24 USD
EPS
-6,32 USD
Beta
0,66
Shares outstanding
59,81 млн
No. of employees
540
Open
31,29 USD
High
31,70 USD
Low
30,44 USD
Mkt. cap
1,82 млд
Avg. vol.
1,24 млн
Volume
153,01 миң
52-wk high
45,99 USD
52-wk low
22,24 USD
EPS
-6,32 USD
Beta
0,66
Shares outstanding
59,81 млн
No. of employees
540
News stories
From web sources and news partners
The Korea Times
·
56 мүнөт мурун
Nasdaq, S&P 500 fall over 1% in run-up to Nvidia results, Anthropic debut
ChartMill
·
1 саат мурун
Today's S&P 500 Top Movers: Tyson Foods Leads Gainers, Lumentum Leads Decliners
TradingView
·
2 саат мурун
Forget Nvidia—Wall Street Sees S&P 500 at 8,900, Putting These ETFs in Play
Stocktwits
·
1 саат мурун
Morgan Stanley’s Mike Wilson Is Bullish On S&P 500 With A 15% Upside View For 2027
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc